NEW YORK (Reuters Health) – Men ages 75 to 80 years old with a prostate specific antigen (PSA) level less than 3 ng/mL are unlikely to experience life-threatening…
NEW YORK (Reuters Health) – In older prostate cancer patients with a biochemical recurrence, cancer anxiety predicts earlier use of androgen deprivation therapy (ADT), new research shows. This…
NEW YORK (Reuters Health) – New evidence indicates that elevated serum levels of ionized calcium may predict the risk of death from prostate cancer. If verified in future…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
NEW YORK (Reuters Health) – Patients with rectal cancer whose disease is downstaged with neoadjuvant radiation therapy have better survival than their peers who fail to respond to…
NEW YORK (Reuters Health) – Yearly gynecological examinations fail to identify early stage ovarian cancer in women with a mutation in the BRCA1 or BRCA2 gene, a Dutch…
NEW YORK (Reuters Health) – New research suggests that B-cell clones may be a useful early marker for chronic lymphocytic leukemia (CLL) since they are found in nearly…
NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – In premenopausal women with endocrine-responsive early breast cancer, addition of the bisphosphonate zoledronic acid to endocrine therapy significantly improves disease-free survival, physicians in…
With special guest Vince Papale, The Cancer Foundation For Personal Appearance hosts an event to promote cancer research, treatment and style. For more information, please visit: The Cancer…